Business, energy, technology, markets and global industry news from Business News Today

Intermountain Health

PharmaDeviceNews Intermountain Health
A patient receives an oncology infusion as Estrella Immunopharma advances EB103 into the dose-expansion phase of the STARLIGHT-1 trial following early durable responses in advanced B-cell non-Hodgkin lymphoma. Representative image.
Pharma & Biotech

Can Estrella’s EB103 challenge established CAR-T therapies in B-cell lymphoma?

Estrella has added Intermountain Health LDS Hospital as the fifth site in its Phase 1/2 STARLIGHT-1 study of EB103. Earlier testing found complete responses in five evaluable patients at the higher dose, but the small uncontrolled dataset and the company's financing position remain important development considerations.

Read More
A radiologic technologist operating an MRI scanner in a hospital setting. Representative image illustrating how AI-powered platforms like Vista AI are transforming MRI acquisition workflows across brain, spine, and cardiac imaging.
Medical Devices & Diagnostics

Vista AI raises $29.5m to expand automated MRI scanning beyond cardiology

Vista AI, a U.S.-based medical imaging software company specializing in AI-powered MRI automation, has raised $29.5 million in Series B financing to accelerate its product roadmap and scale adoption across U.S. hospitals and imaging centers. The funding round, announced on January 14, 2026, includes strategic investments from leading health systems such as Cedars-Sinai Health System,

Read More